You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Caris Target Now for Ovarian Cancer
Sheila Walcoff, Amy Jensen Cunniffe, Gary Palmer
Amy Jensen Cunniffe, Leonhard Pollack, Mark Pittman
Caris will exclusively offer Signal's Myeloma Prognostic Risk Signature, or MyPRS, test to community-based hematologists and medical oncologists across the US.
Bernd Brust, Nicolas Barthelemy, Andy Tasinato, Elodie Ristorcelli, Gherici Hassaine, Dan Holterman, Wang-Juh Chen, Jorge Schettini, Tassilo Hornung
Sven Beushausen, Andy Tasinato, Elodie Ristorcelli, Gherici Hassaine, Dan Holterman, Wang-Juh Chen, Jorge Schettini, Tasilo Hornung
"The recent biomarker additions expand the potential clinical utility to include women who face therapeutic ambiguity earlier in the disease continuum -- a group representing nearly 50 percent of all breast cancer patients," the company said.
Ian Walker, Ian Abercrombie, Stefan Gruenwald
Les Paul, Anthony Maida
The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.
According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.
The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.
In Nature this week: the largest known collection of human genetic variants, and more.